InvestorsHub Logo
Followers 62
Posts 7549
Boards Moderated 1
Alias Born 01/02/2003

Re: None

Thursday, 04/06/2023 9:24:55 AM

Thursday, April 06, 2023 9:24:55 AM

Post# of 425923
It has been 8 years since Eddingpharm took on the job of getting approval for Vascepa in mainland China...When can Amarin expect this to happen?...The new Amarin CEO will be anxious to look into this...It possibly can happen this year.

CVD is a problem in China, but Amarin will have to lower its price for Vascepa in return for the expected huge volume of patients, who will be helped to reduce their heart attacks and strokes....

Vascepa can not only be effective in reducing patient's health problems in China, but can also be effective in reducing hospital costs in China.

Amarin needs a V.P. for China.
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent AMRN News